A patient-centered network approach to multidisciplinary-guideline development: a process evaluation

Table 5 Time investments for phase 2: guideline development

Guideline development groups and number of participants	Mean percentage of participation in *regular meetings*(number of meetings)	Median hours spent per participant in *regular meetings*(range)	Total hours^aspent in *regular meetings* per development group	Total hours in *additional meetings*(number of participants)	Median extra hours per participant (range)	Total extra hours^bper development group	Total hours^cin the development phase
MoG: general infertility; n = 7	92 (10)	40 (22.5–50)	258	7 (1)	58 (40–60)	348	613
MoG: unexplained infertility; n = 6	85 (10)	47 (18–72)	240	15 (3)	58 (50–60)	290	545
MoG: male infertility; n = 6	94 (8)	24 (12–56)	135	8 (2)	39 (18–50)	195	338
MoG: semen analysis; n = 5	88 (5)	30 (10–35)	132	-	48 (46–50)	192	324
MuG; n = 11	77 (11)	30 (21–55)	254	38 (10)	31 (2–51)	310	602
*Subtotal*			1019	68		1335	*2422*
Steering committee n = 7	87 (11)	25 (15–77)	152	39 (4)	15 (3–52)	90	281
Project coordinator ^c						1794 ^c	*1794* ^c
Total			1171	107		3219	4497

MoG = Monodisciplinary guideline, MuG = multidisciplinary guideline.
Regular meetings are meetings necessary for the development of the guidelines.
Additional meetings are meetings necessary for discussing and refining the consistency of the guidelines.
Extra time investments are the hours participants needed to formulate key questions, review, select and assess evidence, write, review and revise draft guidelines, secure alignment of the guidelines and manage Wikifreya.
^aTotal hours for regular meetings are corrected for questionnaire non-responders (mean participation rate x number of meetings x median time investments).
^bTotal extra hours are corrected for questionnaire non-responders [(number of participants per development group-1) x median extra time per participant].
^cThe project coordinator’s meeting hours are included per development group; his extra hours are given separately.

ISSN: 1748-5908